MYL - マイラン (Mylan N.V.)

MYLのニュース

   Active Pharmaceutical Ingredients (API) Market : COVID-19 Impact Analysis with Size, Share, Industry Outlook and Future Scope, Leading Players are Pfizer, Novartis AG, Sanofi, Eli Lilly and Company., Mylan N.V., Piramal Pharma Solutions  2020/11/17 11:13:41 OpenPR
Analysis and discussion of important industry trends, market size, and market share estimates are revealed in the Active Pharmaceutical Ingredients (API) Market research report. Further, manufacturer can adjust production according to the conditions of demand which are analyzed here. The
   Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan  2020/11/16 12:30:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. Pfizer Chairman and Chief Executive Officer Dr. Albert Bourla said, “We are proud to have completed the combination of Upjohn and Mylan to create Viatris and pleased to have delivered value to our shareholders through this transaction. I want to express my gratitude to our Upjohn colleagues for their dedicati
   PDE Inhibitors Market To 2020 - 2027 Analysis | Leading Players, Industry Updates, Future Growth | Mylan N.V., Eli Lilly and Company, AstraZeneca  2020/11/12 12:00:25 OpenPR
PDE Inhibitors Market research report deals with many parameters in depth to satisfy the requirements of business or clients. Market segmentation is also covered in detail in this report by considering several aspects that is sure to help businesses out
   Osteonecrosis Treatment Market Analysis by Atnahs, Teva Pharmaceutical Industries Ltd, Mylan N.V, Integra LifeSciences Corporation  2020/11/11 18:26:43 OpenPR
Osteonecrosis Treatment Market By Therapy (Stem Cell Therapy, Joint Replacement Therapy), Treatment (Medication, Surgery), Route of Administration (Oral and Parenteral), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific,
   Global Developmental Dyspraxia Drug Market In Deep Analysis, Expert Reviews and Precise Outlook 2027 || Eli Lily & Company, Novartis AG, Mylan N.V., Tris Pharma, Inc  2020/11/11 14:21:38 OpenPR
Databridgemarketresearch.com Present “Global Developmental Dyspraxia Drug Market– Industry Trends and Forecast to 2027” new report to its research database. The report spread No of pages: 350 No of Figures: 60 No of Tables: 220 in it. Global Developmental Dyspraxia Drug
   Active Pharmaceutical Ingredients (API) Market : COVID-19 Impact Analysis with Size, Share, Industry Outlook and Future Scope, Leading Players are Pfizer, Novartis AG, Sanofi, Eli Lilly and Company., Mylan N.V., Piramal Pharma Solutions  2020/11/17 11:13:41 OpenPR
Analysis and discussion of important industry trends, market size, and market share estimates are revealed in the Active Pharmaceutical Ingredients (API) Market research report. Further, manufacturer can adjust production according to the conditions of demand which are analyzed here. The
   Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan  2020/11/16 12:30:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. Pfizer Chairman and Chief Executive Officer Dr. Albert Bourla said, “We are proud to have completed the combination of Upjohn and Mylan to create Viatris and pleased to have delivered value to our shareholders through this transaction. I want to express my gratitude to our Upjohn colleagues for their dedicati
   PDE Inhibitors Market To 2020 - 2027 Analysis | Leading Players, Industry Updates, Future Growth | Mylan N.V., Eli Lilly and Company, AstraZeneca  2020/11/12 12:00:25 OpenPR
PDE Inhibitors Market research report deals with many parameters in depth to satisfy the requirements of business or clients. Market segmentation is also covered in detail in this report by considering several aspects that is sure to help businesses out
   Osteonecrosis Treatment Market Analysis by Atnahs, Teva Pharmaceutical Industries Ltd, Mylan N.V, Integra LifeSciences Corporation  2020/11/11 18:26:43 OpenPR
Osteonecrosis Treatment Market By Therapy (Stem Cell Therapy, Joint Replacement Therapy), Treatment (Medication, Surgery), Route of Administration (Oral and Parenteral), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific,
   Global Developmental Dyspraxia Drug Market In Deep Analysis, Expert Reviews and Precise Outlook 2027 || Eli Lily & Company, Novartis AG, Mylan N.V., Tris Pharma, Inc  2020/11/11 14:21:38 OpenPR
Databridgemarketresearch.com Present “Global Developmental Dyspraxia Drug Market– Industry Trends and Forecast to 2027” new report to its research database. The report spread No of pages: 350 No of Figures: 60 No of Tables: 220 in it. Global Developmental Dyspraxia Drug
   UnitedHealth, Express Scripts settle ERISA claims over EpiPen pricing  2020/10/02 21:03:02 Reuters
UnitedHealth Group Inc and Express Scripts Holdings have settled lawsuits claiming that their pursuit of rebates and other discounts on the allergy injection EpiPen from Mylan NV drove up the medication's price, violating their fiduciary duties under the federal Employee…
   Global Reversible Airway Diseases Treatment Market 2020: Covering Competitive Scenario And Dynamics By Mylan N.V., Boehringer Ingelheim International GmbH, Regeneron, Sanofi, Genentech, Inc. (F. HoffmannLa Roche Ltd), Novartis AG  2020/10/01 06:12:27 OpenPR
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Global Reversible Airway Diseases Treatment Market, By Type (Bronchodilators, Cytotoxic Drugs, Antibiotics, Others), Treatment (Chest X Ray, CT Scan, Lung Therapies, Surgery Transplant and Medications), Diseases
   Carboplatin Market In-Depth Analysis Of Competitive Landscape, Executive Summary, Development Factors 2026(Fresenius Kabi, Mylan, Qilu)  2020/09/30 11:26:30 OpenPR
Los Angeles, United State, – – QY Research recently added a research report, Global Carboplatin Market Research Report 2020 to its ever-increasing repository. The research report discusses the future of the global Carboplatin market. It highlights the drivers and restraints
   Drug Addiction Treatment Market Strategic Insights 2020 with analysis of Leading Players: Pfizer, Indivior, Novartis, Alkermes, Cipla, Mylan, Dr. Reddy's Laboratorie, etc.  2020/09/30 07:31:40 OpenPR
The Global Drug Addiction Treatment Market research study takes a comprehensive approach towards studying the key trends influencing the growth of this sector. The report comprises data that offers an in-depth insight into the business sector. The research report focuses
   Outstanding Growth of Opioids Drug Market is estimated to reach $11.8 Billion by 2025 | International Company’s - J&J, Teva, Mylan, Pfizer, Mallinckrodt  2020/09/29 15:23:18 OpenPR
Global Opioids Drug Market Synopsis: The Opioids Drug Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Opioids Drug Market size to maintain the average annual growth rate of 0.83% from $11.1

calendar